Spots Global Cancer Trial Database for nelfinavir mesylate
Every month we try and update this database with for nelfinavir mesylate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00589056 | Lung Cancer | cisplatin etoposide nelfinavir mesy... protein express... immunohistochem... laboratory biom... biopsy radiation thera... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
| Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme | NCT00915694 | Brain and Centr... | nelfinavir mesy... temozolomide adjuvant therap... radiation thera... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer | NCT03050060 | Metastatic Kidn... Recurrent Lung ... Stage IV Cutane... Stage IV Renal ... Stage IV Lung N... | Atezolizumab Hypofractionate... Laboratory Biom... Nelfinavir Mesy... Nivolumab Pembrolizumab | 18 Years - | University of Washington | |
| Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma | NCT03829020 | Recurrent Plasm... Refractory Plas... | Bortezomib Metformin Hydro... Nelfinavir Mesy... | 18 Years - | Mayo Clinic | |
| Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma | NCT00003008 | Sarcoma | indinavir sulfa... nelfinavir mesy... paclitaxel ritonavir saquinavir mesy... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
| Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma | NCT00233948 | Adult Liposarco... Recurrent Adult... Stage III Adult... Stage IV Adult ... | nelfinavir mesy... biopsy laboratory biom... pharmacological... gene expression... western blottin... reverse transcr... immunoenzyme te... | 18 Years - | City of Hope Medical Center | |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
| A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 | NCT00002185 | Sarcoma, Kaposi HIV Infections | Nelfinavir mesy... | 13 Years - | NIH AIDS Clinical Trials Information Service | |
| Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma | NCT03829020 | Recurrent Plasm... Refractory Plas... | Bortezomib Metformin Hydro... Nelfinavir Mesy... | 18 Years - | Mayo Clinic | |
| Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer | NCT01068327 | Adenocarcinoma ... Stage III Pancr... | gemcitabine hyd... leucovorin calc... fluorouracil nelfinavir mesy... stereotactic bo... hypofractionate... therapeutic con... | 19 Years - | University of Nebraska | |
| Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma | NCT03077451 | Recurrent Kapos... Skin Kaposi Sar... | Laboratory Biom... Nelfinavir Mesy... | 18 Years - | AIDS Malignancy Consortium |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
